$SPNT

SiriusPoint Ltd

SiriusPoint is a Bermuda-headquartered global specialty underwriter of insurance and reinsurance. It serves individuals and organizations through its Insurance & Services and Reinsurance segments, underwriting Accident & Health, Property & Casualty, and Other Specialties. Its products include international medical and travel insurance, professional liability, commercial auto, aviation, marine and energy, credit, surety, mortgage, and catastrophe coverage. SiriusPoint also provides medical management and emergency travel assistance services through International Medical Group, and financial and professional lines in Europe through Alta Signa. SiriusPoint earns money from underwriting insurance and reinsurance, service fees from its consolidated managing general agents, and investment results. It distributes primary insurance through program administrators and managing general agents, and obtains most reinsurance business through intermediaries representing ceding companies. Its reinsurance customers include insurance and reinsurance companies, government entities, and other risk-bearing vehicles.

AlphAI earnings readthird quarter 2026 · NOV 5SiriusPoint Reports Third Quarter 2026 Results and Announces LPT on Remaining Run-Off ReservesVerdict: solid

Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.

0
1
0

No SEC Form 4 filings for $SPNT in the last 30 days.

See all $SPNT insider activity →
Low

SiriusPoint Earnings Call Highlights Profitable Growth

SiriusPoint (SPNT) reported Q3 earnings with a 90.1% core combined ratio, $76M underwriting income, and 17.6% operating ROE, exceeding targets. Nine-month results showed 14% insurance growth, 7% premium rise, and 15.8% ROE. Management highlighted strong capital, pipeline, and a $200M capital release from a loss portfolio transfer, but noted competitive pricing and regulatory uncertainty.

RiverStone assumes $400 million SiriusPoint legacy portfolio

RiverStone International assumed a $400M legacy reinsurance portfolio from SiriusPoint, its first deal with the company. SiriusPoint CEO Scott Egan stated the transaction simplifies its business and strengthens capital.

Oppenheimer raises SiriusPoint stock price target on earnings beat

Oppenheimer raised its price target on SiriusPoint Ltd (NYSE: SPNT) to $31 from $27, citing strong Q3 2026 earnings. The company reported adjusted earnings of $0.74 per share, beating estimates, with revenue of $867.6 million. Oppenheimer updated its 2026 EPS estimate to $2.83 and introduced a 2028 estimate of $2.90, excluding one-time costs. SiriusPoint's core combined ratio remained steady at 90.1%.

SPNT sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning SPNT (SiriusPoint Ltd). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent SPNT coverage spans earnings, corporate actions and financial news.

What's driving SPNT

  • No new catalyst; the recap reinforces existing view of strong profitability and capital release.

    tipranks.com · Nov 15, 2026

  • RiverStone International assumed a $400M legacy reinsurance portfolio from SiriusPoint, its first deal with the company. SiriusPoint CEO Scott Egan stated the transaction simplifies its business and strengthens capital.

    coverager.com · Nov 10, 2026

  • Target raise signals bullish outlook.

    investing.com · Nov 9, 2026

  • The LPT is positioned as a major reduction in legacy reserve uncertainty, with a stated BSCR uplift and capital release that can support buybacks and growth.

    finance.yahoo.com · Nov 6, 2026

  • SiriusPoint Ltd. reported a 4% decline in Q3 net income to $87M, with a combined ratio worsening by 1 point to 90%. Gross written premiums rose 14% to $991M, led by a 20% increase in insurance and services premiums to $673M, according to The Royal Gazette.

    businessinsurance.com · Nov 6, 2026

AlphAI scores every news story that mentions SPNT with an AI model for sentiment and relevance, and aggregates insider trades from SiriusPoint Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $SPNT

Score

SiriusPoint Earnings Call Highlights Profitable Growth

SiriusPoint (SPNT) reported Q3 earnings with a 90.1% core combined ratio, $76M underwriting income, and 17.6% operating ROE, exceeding targets. Nine-month results showed 14% insurance growth, 7% premium rise, and 15.8% ROE. Management highlighted strong capital, pipeline, and a $200M capital release from a loss portfolio transfer, but noted competitive pricing and regulatory uncertainty.

Oppenheimer raises SiriusPoint stock price target on earnings beat

Oppenheimer raised its price target on SiriusPoint Ltd (NYSE: SPNT) to $31 from $27, citing strong Q3 2026 earnings. The company reported adjusted earnings of $0.74 per share, beating estimates, with revenue of $867.6 million. Oppenheimer updated its 2026 EPS estimate to $2.83 and introduced a 2028 estimate of $2.90, excluding one-time costs. SiriusPoint's core combined ratio remained steady at 90.1%.

SiriusPoint (SPNT) Q3 2026 Earnings Call Transcript

SiriusPoint (SPNT) reported Q3 2026 earnings, highlighting 20% growth in insurance and services, a core combined ratio of 90.1%, and an operating return on equity of 17.6%. The company also announced a loss portfolio transfer agreement to reduce legacy runoff exposures, freeing up over $200 million in capital. Year-to-date, insurance and services grew by 14%, with a core combined ratio of 90.1% and an operating return on equity of 15.8%.

SiriusPoint posts $87M profit, down 4%

SiriusPoint Ltd. reported a 4% decline in Q3 net income to $87M, with a combined ratio worsening by 1 point to 90%. Gross written premiums rose 14% to $991M, led by a 20% increase in insurance and services premiums to $673M, according to The Royal Gazette.

SiriusPoint run-off deal expected to release $200m

SiriusPoint announced a deal to release $200M in capital via a loss portfolio transfer with RiverStone. Q3 net income was $87M, down from $90.7M YoY, but operating net income rose to $103.2M. Core gross written premiums grew 13.7% to $990.6M, with Insurance & Services driving growth. CEO Scott Egan highlighted 17.6% operating returns on equity, exceeding targets.

$SPNTMedEarnings

SiriusPoint Reports Third Quarter 2026 Results and Announces LPT on Remaining Run-Off Reserves

SiriusPoint Ltd (SPNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. SiriusPoint Reports Third Quarter 2026 Results and Announces LPT on Remaining Run-Off Reserves HAMILTON, Bermuda, November 5, 2026 - SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE:SPNT), a global specialty underwriter, today announced results for its third quarter ended

$SPNTLowExec change· appointed

SiriusPoint Ltd (SPNT): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

SiriusPoint Ltd (SPNT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. PRESS RELEASE SiriusPoint Appoints John Sauerland to Board of Directors HAMILTON, Bermuda, November 3, 2026 – SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty underwriter, today announced the appointment of John Sauerland to the Board of Director

SiriusPoint appoints former Progressive CFO to board

SiriusPoint Ltd. (NYSE:SPNT) appointed John Sauerland to its board, effective January 1, 2027. Sauerland has over 35 years of insurance experience, most recently as CFO at Progressive Insurance. He brings governance experience from multiple board positions. SiriusPoint, a global specialty underwriter, has $3.0 billion in total capital and holds high ratings from AM Best, Fitch, S&P, and Moody’s.

Related tickers